W.R. Grace Looks To Make Large 'Strategic' Buy

Chemicals maker W.R. Grace & Co, which is operating under Chapter 11 bankruptcy protection, wants to make an acquisition that would "significantly" bolster its business.

The company's board started investigating a "highly confidential potential strategic transaction" last month, according to a filing with U.S. bankruptcy court.

Grace is now asking the court to seal any disclosure of the seller. The company needs the court's permission to do anything outside normal business operations, including acquisitions.

"The board determined in its business judgment that this proposed transaction would significantly enhance Grace's business plan and growth strategy in coming years," the company said in the filing.

In a statement to Reuters, W.R. Grace declined to elaborate. "If we are successful, we will announce the transaction publicly," spokesman Greg Euston said.

Grace makes catalysts used in the chemical and oil refining sectors and construction products.

Given the recent strong results and stock appreciation, it was not immediately clear why the company needs to alter its business model.
The company's first-quarter results handily beat Wall Street's expectations. Chief Financial Officer Hudson LaForce told Reuters in April that sales in W.R. Grace's construction-related businesses are the strongest they've been in three years.

The Columbia, Maryland-based company will meet with a U.S. district judge next Tuesday to discuss its exit from bankruptcy protection.

W.R. Grace has taken care of nearly all claims related to its 2001 bankruptcy, though three groups of creditors still have claims against the company.
The company initially filed due to the large number of claims against its asbestos business. In 2008 it agreed to set up a trust fund to pay victims' health claims. The trust will be set up as soon as the company exits bankruptcy.

 W.R. Grace's largest shareholders include Peninsula Capital Advisors, Fidelity, Vanguard and BlackRock Inc.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
19.05.2025 • NewsChemie

OQ Chemicals firmiert künftig wieder als Oxea

Der bis Mai 2020 unter dem Namen Oxea bekannte Hersteller von Oxo-Zwischenprodukten und Oxo-Derivaten, der zwischenzeitlich zum Omanischen Energieunternehmen OQ gehörte und unter dem Namen OQ Chemicals firmierte, kehrt zu seinem alten Namen und seinen Wurzeln zurück.